Device
Rapid diagnostics
Rapid diagnostics is a medical device with 3 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
1(33%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
1
33%
Ph phase_3
1
33%
Ph phase_4
1
33%
Phase Distribution
0
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution3 total trials
Phase 3Large-scale testing
1(33.3%)
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
1(33.3%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(2)
Completed(1)
Detailed Status
Recruiting1
Not yet recruiting1
Completed1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 31 (33.3%)
Phase 41 (33.3%)
N/A1 (33.3%)
Trials by Status
recruiting133%
not_yet_recruiting133%
completed133%
Recent Activity
1 active trials
Showing 3 of 3
recruitingphase_4
EaRly impAct theraPy With Ceftazidime-avibactam Via rapID Diagnostics
NCT05979545
not_yet_recruitingnot_applicable
Improved Diagnostics, Treatment and Follow-up of Acute Exacerbation of Chronic Obstructive Pulmonary Disease
NCT06105814
completedphase_3
Optimizing the Management of Acute Diarrhoeal Disease
NCT02803827
Clinical Trials (3)
Showing 3 of 3 trials
NCT05979545Phase 4
EaRly impAct theraPy With Ceftazidime-avibactam Via rapID Diagnostics
NCT06105814Not Applicable
Improved Diagnostics, Treatment and Follow-up of Acute Exacerbation of Chronic Obstructive Pulmonary Disease
NCT02803827Phase 3
Optimizing the Management of Acute Diarrhoeal Disease
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3